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Abstract
Background: The most common cause of perihilar obstruction is cholangiocarcinoma, especially in Thailand.
Benign perihilar stricture represents less than 20% of cases. IgG4-related disease and IgG4-related sclerosing
cholangitis, however, have been receiving increased recognition. Isolated IgG4-related sclerosing cholangitis is less
common. The preoperative diagnosis of IgG4-related sclerosing cholangitis without pancreatic involvement is very
difficult because the clinical presentation and preoperative evaluation are extremely difficult to distinguish from
perihilar cholangiocarcinoma.
Case presentation: We report the case of a 56-year-old man who presented with obstructive jaundice with
preoperative imaging showing proximal common bile duct obstruction. He underwent right lobe liver hepatectomy
with extrahepatic bile duct resection and regional lymph node dissection due to high suspicion of malignancy. The
pathological report showed severe acute and chronic inflammation of the bile duct with morphology and
immunohistochemistry suggestive of IgG4-related sclerosing cholangitis.
Conclusions: IgG4-related sclerosing cholangitis with perihilar obstruction should be considered even in areas
where cholangiocarcinoma is endemic.
Keywords: IgG4, IgG4-related sclerosing cholangitis, Cholangiocarcinoma, Benign biliary stricture, Sclerosing
cholangitis
Background
Thailand has the highest incidence of cholangiocarci-
noma (CCA) worldwide, especially in the northeast area
[1]. Malignant appearing perihilar obstruction is com-
monly associated with CCA until proven otherwise [2].
The incidence of benign obstruction reported in litera-
ture ranges from 8–17.4% [2–13]. IgG4-related disease
(IgG4-RD) is an emerging entity increasingly described
in the literature. Autoimmune pancreatitis is the most
common organ involvement [14–16]. IgG4-related scler-
osing cholangitis (IgG4-SC) is reported worldwide in
Western and Asian populations [5, 11–13]. Distal biliary
stricture is the most common presentation in association
with autoimmune pancreatitis (AIP). However, IgG4-SC
with proximal perihilar biliary obstruction in the absence
of AIP is uncommon [12]. The clinical manifestation is
similar to CCA, especially for proximal biliary stricture.
Diagnosis can be established by clinical suspicion with
diagnosis criteria [16–18]. Steroid treatment should be
empirically provided in suspected cases [18]. A minority
of cases have been managed with surgical resection, usu-
ally in the case of isolated biliary strictures. We report a
case of IgG4-SC in the absence of AIP that was pre-
operatively misdiagnosed as CCA, and the patient
underwent right hemihepatectomy with bile duct resec-
tion and biliary enteric reconstruction. The pathological
report showed lymphoplasmacytic infiltration with
IgG4-positive plasma cells. The ultimate diagnosis was
IgG4-associated cholangitis.
Case presentation
A 56-year-old Asian male patient from northeast,
Thailand with an unremarkable past-medical history was
referred from a primary care center with painless
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obstructive jaundice for two weeks. He was previously
admitted to a private hospital, and abdominal computed
tomography (CT) was performed. He underwent endo-
scopic retrograde cholangiopancreatography (ERCP) and
trans-ampullary biopsy and brush cytology. A plastic bil-
iary stent was inserted across the obstruction point. At the
time of the initial visit to the out-patient clinic, physical
examination revealed a mildly obese patient, generally co-
operative, with marked icteric sclera and pruritus. No acute
distress was noted. There were no clinical signs of an ab-
dominal mass or palpable supraclavicular lymph node.
At the time of referral, laboratory analysis showed the
following liver function test results: total bilirubin
16.0 mg/dL, direct bilirubin 11.7 mg/dL, alkaline phos-
phatase (ALP) 319 U/L (normal 50–136 U/L), gamma
glutamyl transferase (GGT) 33 U/L (normal 15–85 U/L),
aspartate aminotransferase (AST) 59 U/L (normal 15–37
U/L), alanine aminotransferase (ALT) 55 U/L (normal
30–65 U/L), white blood cell count 12,040/cumm, plate-
let count 464,000/cumm, hemoglobin 11.5 g/L, CEA
1.9 ng/ml (0–4.6 ng/mL), CA 19–9 19.8 U/mL (normal
0–39 U/mL), normal serum electrolytes, normal renal
function. HBsAg, anti-HCV and anti-HAV were all
negative.
Transabdominal ultrasonography was performed at a
private hospital and showed dilatation of both intrahepa-
tic bile ducts. The common bile duct was not dilated.
No gallstone was found. Abdominal CT showed a focal
short segment, sheet-like, symmetric thickening of the
common hepatic duct causing nearly complete obstruc-
tion just below the bifurcation of the right and left intra-
hepatic bile ducts and dilatation of the left intrahepatic
duct (Fig. 1). At private hospital, he underwent ERCP
which revealed a common hepatic duct stricture of ap-
proximately 1–2 cm just below the biliary confluence
and dilatation of both the right and left intrahepatic bile
ducts (Fig. 2). Brush cytology and trans-ampullary biopsy
were performed. The cytological reports and trans-
ampullary biopsy pathological reports were benign bile
duct epitheliums without cellular atypia.
At the time of referral, chest and mediastinum CT
were performed, and the results showed no pulmonary
metastasis or new lesions, along with a decreased degree
of intrahepatic bile duct dilatation. Magnatic resonance
imaging (MRI) and magnetic resonance cholangiopan-
creatography was not done in this patient. Ultimately,
surgical resection was planned after adequate biliary
drainage due to high suspicion of CCA.
At surgery, the abdomen was opened by inverted J
skin incision. There was no metastatic disease. There
was a hard palpable lesion at the common bile duct
along the common hepatic duct (Fig. 3). Extended right
hepatic lobectomy with en-bloc excision of the gallblad-
der and extrahepatic bile duct with lymphadenectomy
was performed, followed by reconstruction using Roux-
en-Y hepatico-jejunostomy anastomosis to the left intra-
hepatic bile duct. Intraoperative frozen sections of the
resection margins of the distal common bile duct were
negative for malignancy.
The pathological examination of the surgical specimen
revealed severe acute and chronic inflammation with
dense lymphoplasmacytic infiltration, storiform fibrosis
and obliterative phlebitis of the common hepatic duct
and right and left hepatic ducts, with all margins in-
flamed (proximal bile duct margin, distal bile duct mar-
gin and hepatic parenchymal margin) as shown in Fig. 4.
All lymph nodes including the celiac, common hepatic,
retropancreatic and hepatoduodenal lymph node groups
were negative for malignancy. After review of the patho-
logical specimens by a pathologist, we requested further
immunohistochemical analysis for IgG4-related disease,
and the results showed IgG4-positive plasma cells at 80
Fig. 1 Abdominal CT showing focal short segment sheet-like thickening of proximal common bile duct with enhancement. a: axial view showing
sheet-like thickening of common hepatic duct wall (arrow); note the normal pancreas (star). b: coronal view showing focal short segment, sheet-
like, symmetric thickening of common hepatic duct causing nearly complete obstruction of common hepatic duct just below bifurcation (white
arrow with blue edge) of right and left intrahepatic bile ducts and dilatation of left intrahepatic duct (white arrow)
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cells/HPF (Fig. 5) for the bile duct wall, with the lymph
node showing mixed follicular and paracortical lymphoid
hyperplasia with markedly increased polytypic plasma
and an IgG4/IgG ratio above 40%.
Postoperatively, the patient suffered from intra-
abdominal infection from hepatico-jejunostomy anasto-
mosis leakage that required re-laparotomy and repair of
the anastomosis and abdominal toilet. After the re-
laparotomy, he recovered uneventfully. The serum IgG4
level obtained after surgery was above 7230 mg/dL. At
6 months follow-up, he had recovered well and main-
tained normal activity with no recurrence of the disease.
His laboratory analysis results were normal, and abdom-
inal CT showed no other biliary stricture. There is no fur-
ther treatment after discussing with gastroenterologist.
Discussion
The most common cause of perihilar biliary obstruction
is perihilar CCA (Klatskin tumors) [2], especially in
Thailand, which has the highest prevalence of both
intrahepatic and extrahepatic CCA worldwide due to
parasitic infestation [1]. Surgical resection including
major hepatic resection remains the mainstay of treat-
ment for perihilar CCA [19]. According to the AJCC
classification 7th edition, the extrahepatic bile duct is di-
vided into the perihilar (proximal common bile duct and
hilar) and distal common bile duct [20]. The incidence of
benign proximal biliary obstruction preoperatively diag-
nosed as hilar CCA in which the final histological examin-
ation of resection specimens shows benign stricture is
approximately 8–17.3% [2–13]. One type of benign perihi-
lar stricture is IgG4-RD. IgG4-RD is an emerging systemic
condition characterized by mass-forming sclerosing le-
sions, elevated serum IgG4 concentrations, and extensive
tissue infiltration by IgG4-positive plasma cells. IgG4-RD
can involve any organ, but the most common is the
Fig. 2 ERCP show stricture of common hepatic duct just below
hepatic confluence
Fig. 3 Intraoperative findings and gross specimen. a: tumor at hepatic hilum (arrow). b: left main intrahepatic duct (arrow). c: gross specimen
after complete resection showing mass at proximal common bile duct just below hepatic confluence (arrow). d: diffuse bile duct thickening with
marked focal thickening at common hepatic duct (arrow)
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pancreas. IgG4-SC is the sixth most common type of
organ involvement [14]. IgG4-SC is a characteristic type of
sclerosing cholangitis with dense infiltration of IgG4-
positive plasma cells and extensive fibrosis in the bile duct
wall [17]. IgG4-SC concomitant with pancreatic involve-
ment or AIP is the most common presentation, while iso-
lated IgG4-SC is uncommon. The previously reported
incidence of perihilar stricture due to IgG4-SC without
pancreatic involvement represents 4.8–9.1% of benign bil-
iary stricture [12]. Zen et al. reported the prevalence and
incidence of proximal IgG4-SC to be 1.0 and 0.3 per
100,000 population, respectively [17].
The diagnosis of IgG4-SC is crucial. Because IgG4-SC
lacks any highly specific diagnostic features, a high index
of suspicion in all patients with unexplained biliary stric-
tures can lead to the most accurate diagnosis. Some au-
thors have proposed criteria for the diagnosis of IgG4-
SC. Firstly, Ghazale et al. from the Mayo group proposed
the worldwide acceptance of the HISORt criteria for
IgG4-SC, adopted from previously reported criteria for
AIP including histology of the bile duct, imaging of the
bile duct, serology, other organ involvement and re-
sponse to steroid therapy [15, 18]. Recently, Ohara et al.
reported Japanese and Korean guidelines for the clinical
diagnostic criteria of IgG4-related sclerosing cholangitis
[21]. According to these guidelines, the current case was
definitely diagnosed with IgG4-SC. The most important
clue to diagnosis were three distinct histopathological
findings including markedly dense fibrous tissue in the
background with focal storiform pattern and densely in-
filtrating lymphocytes and plasma cells and obliterative
phlebitis. The IgG4+/IgG+ plasma cell ratio was more
than 40% and IgG4+ plasma cells density was 80cells/
HPFs [18, 21].
Serum IgG4 level is an important part of the diagnosis
of IgG4-SC. However, an increased serum IgG4 level
alone should not be used to diagnose of IgG4-SC.
Ghazale et al. report the sensitivity of serum IgG4 to be
Fig. 4 Left hepatic duct along with common bile duct showing fibrosis and plasma cells. a, H&E x100; b. H&E x200; c, H&E x100 storiform fibrosis
with lymphocytes and plasma cells; d, H&E x200 obliterative phlebitis H&E, Hematoxylin and eosin stain
Fig. 5 Left hepatic duct along with common bile duct showing positive plasma cells. a. IHC x400 of IgG-positive plasma cells. b. IHC x400 of
IgG4-positive plasma cells (80 cells/HPF) IHC, immunohistochemistry
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74% [18]. Oseini et al. report that a cut-off level of
serum IgG4 above 135 or 140 mg/dl shows higher sensi-
tivity, while a serum IgG4 level 4-fold higher than nor-
mal is 100% specific for IgG4-SC [22]. Lytras et al.
report the sensitivity and specificity of serum IgG4 level
to be 50% and 75%, with the positive predictive value
(PPV) and negative predictive value (NPV) of 75% and
50%, respectively. The accuracy of elevated serum IgG4
for the diagnosis of IgG4-SC reached 69% [13]. Ohara et
al. report a large cohort study from Japan that increasing
specificity for preoperative diagnosis by cytology of hilar
involved IgG4-SC to 96.6% when a cut-off level of serum
IgG4 level is 207 mg/dL [23].
Cross-sectional study, CT and MRI have proven difficult
to use for differentiation from CCA [24–27]. IgG4-SC can
present with a focal/segmental or diffused biliary stricture
[26, 27]. Patients with concomitant AIP and other organ
involvement might demonstrate characteristics of organ
involvement that raise suspicions of IgG4-SC. The absence
of other organ involvement could make it more difficult
for a physician to distinguish IgG4-SC from CCA. Some
authors have described image findings for the diagnosis of
IgG4-SC including multifocal biliary strictures, a markedly
thickened bile duct wall (mean wall thickness, 4.9 mm), a
smooth outer margin, a narrow but visible lumen, hyper-
enhancement during the late arterial phase, homogeneous
hyper-enhancement during the delayed phase, concurrent
gallbladder wall thickening and an absence of vascular in-
vasion [27–29].
Recently, Chen L et al. have reported the accuracy rate,
sensitivity, specificity, PPV and NPV of intraductal ultra-
sound (IDUS) with tissue sampling in proximal bile duct
obstruction to be above 90% [30]. The characteristic IDUS
findings for IgG4-SC are circular symmetrical wall thick-
ness, a smooth outer margin, a smooth inner margin and
a homogeneous internal echo in the stricture [31].
Table 1 Review of reported cases of isolated IgG4-associated cholangitis misdiagnosed as perihilar cholangiocarcinoma underwent
surgical resections





1 M 56 Perihilar, CBD/ Jaundice 1646 Hepatic resection with
pancreaticoduodenectomy
Lymphoplasmacytic infiltration
IgG4-positive plasma cell infiltration
Cheung (2008)
[35]





2 NA NA NA/ Jaundice NA Hepatic resection Lymphoplasmacytic infiltration
Moderate IgG4-positive plasma cells
Fujita (2010) [12] 1 M 60 Perihilar/ Jaundice NA Bile duct resection Lymphoplasmacytic infiltration
Diffuse IgG4-positive plasma cells
Lytras (2012) [13] 1 NA NA NA/ NA Negative Hepatic resection Class A (HISORt criteria)
Nguyen-tat
(2012) [36]
1 M 79 Perihilar/ Jaundice 40 Hepatic resection with bile duct
resection
Lymphoplasmacytic infiltration




1 M 70 Perihilar/ Jaundice 1.10 Hepatic resection with bile duct
resection
Lymphoplasmacytic infiltration











Hepatic resection with bile duct
resection
Hepatic resection with bile duct
resection
Lymphoplasmacytic infiltration
IgG4-positive plasma cells > 40%
IgG4-positive plasma cells >50 cells/
HPF
Miki (2015) [39] 1 M 69 Perihilar/ Jaundice 381 Bile duct resection Lymphocyte and plasma cell
infiltration




1 M 60 Perihilar, CBD/ Jaundice,
abdominal pain
80 Bile duct resection Dense fibro-inflammatory infiltration
with lymphoid cells
IgG4-positive plasmacytoid cells








Perihilar/ Jaundice NA Bile duct resection Lymphoplasmacytic infiltration
IgG4-positive cells >50 cells/HPF
Present study 1 M 56 Perihilar/ Jaundice >7230 Hepatic resection with bile duct
resection
Lymphoid and plasma cell infiltration
IgG4-positive plasma cells 80 cells/
HPF
M male, F female, CBD common bile duct, LFT liver function test, HPF high-power field
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Isolated IgG4-SC without AIP is uncommon. Despite
aggressive preoperative evaluation, especially in the cen-
ter that have limitation of resource, it is very difficult to
differentiate IgG4-SC without AIP from CCA. Preopera-
tive histology in biliary stricture remains controversial.
Davidson et al. concluded that there is currently no evi-
dence to support routine histological examination for
the diagnosis of CCA [32]. But his study does not em-
ploy the results of a number of studies that have demon-
strated the value of histology, the role of additional
studies such as fluorescence in situ hybridization (FISH).
Recently, the incorporation of routine cytology and FISH
for evaluation of endoscopic brushings would be an im-
portant role for diagnosis of pancreatobiliary tract malig-
nancy [33]. Some reported cases of IgG4-SC in the
absence of AIP have been misdiagnosed as cholangiocar-
cinoma and treated by surgical resection (Table 1). In
this case, the misdiagnosis was partly because CCA is
very common in Thailand. The clinical manifestation
was similar to CCA. Surgical resection was recom-
mended to these patients because of high suspicion of
CCA that could not be distinguished from benign biliary
stricture. According to current available guidelines, some
authors recommend steroid treatment and waiting for
response to therapy [18, 21].
Conclusions
In conclusion, surgeons should be aware of IgG4-RD as
one of the causes of benign hilar and proximal bile duct
stricture and consider this possibility preoperatively. The
serum IgG4 level and associated other organ involvement
should be investigated. However, the clinical presentation
and imaging study are extremely difficult to distinguish
from malignancy. A high index of suspicion and consider-
ation of diagnostic criteria are important. The accurate
diagnosis of IgG4-SC is important to avoid major surgical
resection in patients with perihilar biliary obstruction.
More invasive studies such as ERCP with IDUS and EUS
show promising results in preoperative diagnosis.
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